Monsanto Announces Licensing Agreement for CRISPR-Cpf1

News   Jan 05, 2017 | Monsanto

 
Monsanto Announces Licensing Agreement for CRISPR-Cpf1
 
 
 
 

RELATED ARTICLES

ACD/Labs Collaboration Provides NMR Data to Brazilian Biodiversity Natural Products Database

News

ACD/Labs announces collaboration with researchers at Brazilian Biodiversity database in support of chemical and pharmaceutical R&D.

READ MORE

New Version of CRISPR Corrects RNA Defects Linked to Huntington’s, ALS

News

Researchers have used CRISPR to correct the molecular mistakes that lead to microsatellite repeat expansion diseases, which include myotonic dystrophy types 1 and 2, the most common form of hereditary ALS, and Huntington's disease.

READ MORE

Circular RNA Linked to Brain Function

News

When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE